A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
批准号:
10656259
负责人:
UTE Martha MOLL
金额:
$58.68万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-07-15 至 2025-06-30
关键词:
AblationAdultAirway DiseaseAllergensApicalAsthmaBasal CellBiogenesisBiosensorBiotinCDK2 geneCell CycleCell Cycle KineticsCell Cycle ProgressionCell Differentiation processCell divisionCellsCentriolesCentrosomeChIP-seqChromatin Remodeling FactorChronicChronic Obstructive Pulmonary DiseaseCiliaClassificationComplexCytoplasmDNA biosynthesisDevelopmentDustE2F transcription factorsEpendymaEpitheliumFamilyFertilityGene ExpressionGenesGeneticGenetic TranscriptionGoalsHomeostasisHost DefenseHumanImpairmentInhalationInheritedInnovative TherapyKnowledgeLung diseasesLung infectionsMammalian OviductsMammalsMapsMass Spectrum AnalysisMissionMitoticMolecularMucociliary ClearanceMusNational Heart, Lung, and Blood InstituteNatural regenerationPathway interactionsPatientsPhasePhenotypePhysiologicalPlantsPlayPopulationPreventionPrimary Ciliary DyskinesiasProcessProliferatingProteinsPublic HealthResearchResolutionRespirationRespiratory Tract InfectionsRoleSARS-CoV-2 infectionSurfaceTestingTimeTissuesTracheaTranscription CoactivatorTranscription RepressorTranscriptional RegulationTrimethoprim-SulfamethoxazoleValidationVisualizationWorkairway epitheliumcell motilitychronic respiratory diseaseciliopathycilium biogenesiscilium motilitydesigndiagnostic strategyfibrotic interstitial lung diseasefluid flowgene networkgenetic corepressorgenome-widehuman diseasein vivoinsightkinetosomelung developmentlung healthlung injurymembermultiple omicsmutantneurogenesisnew therapeutic targetnotch proteinnovelnovel therapeutic interventionpathogenpollutantprogenitorprogramspublic health relevancerespiratorysensorspatiotemporalstem cellstranscription factortumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Multiciliated cells (MCCs) occur in airways, ependyma and oviduct and are crucial for respiration, neurogenesis
and fertility. MCCs nucleate up to 300 motile cilia at their apical surface to generate directional fluid flow. Res-
piratory MCCs are responsible for constantly cleaning airways from inhaled pollutants and pathogens to maintain
pulmonary health (mucociliary clearance). Notably, airway ciliated cells are the primary targets for human SARS-
CoV-2 infections, and impaired clearance by defective MCCs, acquired or inherited as genetic ciliopathies, is
associated with chronic airway infections, COPD and asthma. Motile ciliogenesis is directed by > 600 ciliary
genes via sequential and hierarchically organized activity of MCC transcription factors. However, transcriptional
regulation of multiciliogenesis is only partly deciphered, with major knowledge gaps in the early phases of differ-
entiation which establish MCC fate and orchestrate centriolar amplification. E2f transcription factors, evolution-
arily conserved from plants to mammals, are major regulators of cell cycle. The canonical E2f1-6 regulate ex-
pression of genes controlling DNA replication and the mitotic machinery. In contrast, only a few physiological
scenarios are known where the atypical repressors E2f7 and E2f8 are essential. We recently identified an unex-
pected major new role of E2f7 and E2f8 in motile multiciliogenesis of airways, ependyma and oviducts. We
find E2f7 and E2f8 exclusively expressed in two cell populations of airway epithelium, the cycling basal and the
earliest MCCs progenitors. Notably, ablation of E2f7 in mice causes a profound reduction in basal bodies and
cilia numbers in airways, ependyma and oviduct. Additional loss of E2f8 further exacerbates the phenotype,
indicating physiological cooperation. We will test our hypothesis that E2f7 and E2f8 act as the switch from
proliferating uncommitted progenitors to differentiating MCC progenitors which fundamentally requires overcom-
ing the strict once-per-cell-cycle centriole duplication program of dividing cells. We postulate that E2f7 and E2f78
are critical for decoupling centrosome duplication from cell division. E2f7 and E2f78 achieve this by cooperatively
blocking DNA replication and inducing the alternate S*/G2M*-like phases which enables centriolar biogenesis.
This is followed by mainly E2f7 regulating and balancing the early MCC transcriptional program, thereby safe-
guarding centriolar multiplication. This proposal will comprehensively and systematically identify mechanisms,
molecular partners and their place in the transcriptional MCC hierarchy that underlie this new ciliary function of
E2f7/f8. Aim 1 performs single cell mechanistic and functional analyses of E2f7 and E2f8 in MCCs in primary
organotypic cultures. Aim 2 maps E2f7 and E2f8 within the MCC hierarchy and the alternate cell cycle in early
ciliogenesis. Aim 3 identifies the proximal functional protein interactome of E2f7 and E2f8 in multiciliogenesis
with functional validation. The results will greatly expand our fundamental insights into motile multiciliogenesis
and lay the groundwork for identifying potentially causal roles of dysfunctional E2f7/f8 in cilia-related human
airway and lung diseases, crucial for developing novel therapeutic strategies for their prevention and treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
-
批准号:10450815
-
项目类别:
-
资助金额:$57.72万
-
财政年份:2021
-
负责人:UTE Martha MOLL
-
依托单位:
A novel role for E2fs: E2f7 and E2f8 control motile ciliogenesis
-
批准号:10293097
-
项目类别:
-
资助金额:$57.24万
-
财政年份:2021
-
负责人:UTE Martha MOLL
-
依托单位:
Targeting stabilized mutant p53 protein
-
批准号:9038330
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Targeting stabilized mutant p53 protein
-
批准号:8496336
-
项目类别:
-
资助金额:$33.28万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Mutant p53 as actionable cancer-specific target
-
批准号:10414801
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Targeting stabilized mutant p53 protein
-
批准号:8827721
-
项目类别:
-
资助金额:$35.65万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Targeting stabilized mutant p53 protein
-
批准号:8640903
-
项目类别:
-
资助金额:$34.55万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Mutant p53 as actionable cancer-specific target
-
批准号:10162515
-
项目类别:
-
资助金额:$34.44万
-
财政年份:2013
-
负责人:UTE Martha MOLL
-
依托单位:
Third International Mdm2 Workshop
-
批准号:7000510
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:7008208
-
项目类别:
-
资助金额:$29.43万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:7487702
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:6687834
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
The role of p63 and p73 in cancer
-
批准号:7806553
-
项目类别:
-
资助金额:$31.43万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:6422548
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:6921975
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
The role of p63 and p73 in cancer
-
批准号:8058629
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
The role of p63 and p73 in cancer
-
批准号:8252224
-
项目类别:
-
资助金额:$30.52万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
The role of p63 and p73 in cancer
-
批准号:7659627
-
项目类别:
-
资助金额:$31.26万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
Role of the p53 homolog p73 in cancer
-
批准号:6620858
-
项目类别:
-
资助金额:$30.14万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
The role of p63 and p73 in cancer
-
批准号:7526775
-
项目类别:
-
资助金额:$23.54万
-
财政年份:2002
-
负责人:UTE Martha MOLL
-
依托单位:
海外基金